‘Tell me we’re winning the media battle!’ I imagine Unilever boss Alan Jope barking at his team on Tuesday, following the revelation on Sunday of his rejected £50 billion bid for GlaxoSmithKline’s consumer healthcare arm.
‘Yes, sir,’ replies the flustered PR, ‘Very much so… except for top investor Richard Buxton of Jupiter telling the FT: “The idea of letting the goons at Unilever run [the GSK business] is laughable.”
Already a subscriber? Log in
As the US decides, so can you
Subscribe today and get a $50 Amazon gift card if you correctly predict the next US president.
- Unlimited access to spectator.com.au
- The weekly edition on the Spectator Australia app
- Spectator podcasts and newsletters
- Full access to spectator.co.uk
Or
Unlock this article
You might disagree with half of it, but you’ll enjoy reading all of it. Try your first month for free, then just $2 a week for the remainder of your first year.
Comments
As the US decides, so can you
Subscribe today and get a $50 Amazon gift card if you correctly predict the next US president.
SUBSCRIBE AND ENTERAlready a subscriber? Log in